Compare ROIV & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | DPZ |
|---|---|---|
| Founded | 2014 | 1960 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.4B |
| IPO Year | N/A | 2004 |
| Metric | ROIV | DPZ |
|---|---|---|
| Price | $21.70 | $437.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 22 |
| Target Price | $21.94 | ★ $487.64 |
| AVG Volume (30 Days) | ★ 6.7M | 514.8K |
| Earning Date | 11-10-2025 | 10-14-2025 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | N/A | ★ 5.20 |
| EPS | N/A | ★ 17.13 |
| Revenue | $20,329,000.00 | ★ $4,848,168,000.00 |
| Revenue This Year | N/A | $5.71 |
| Revenue Next Year | $376.94 | $6.43 |
| P/E Ratio | ★ N/A | $25.21 |
| Revenue Growth | N/A | ★ 3.92 |
| 52 Week Low | $8.73 | $392.89 |
| 52 Week High | $22.45 | $500.55 |
| Indicator | ROIV | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 64.86 |
| Support Level | $20.14 | $413.12 |
| Resistance Level | $21.48 | $433.57 |
| Average True Range (ATR) | 0.71 | 9.63 |
| MACD | 0.00 | 2.21 |
| Stochastic Oscillator | 65.96 | 98.12 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Domino's is a restaurant operator and franchiser with over 21,500 global stores across more than 90 international markets at the end of the second quarter of 2025. The firm generates revenue through the sales of pizza, wings, salads, sandwiches, and desserts at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's US and Canadian restaurants. With roughly $19.2 billion in 2024 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Little Caesars, and Papa John's.